{"database": "lobbying", "table": "lobbying_activities", "rows": [[2181466, "1d444abe-71da-4f69-b69a-237b8cab8e41", "Q3", "RED+BLUE STRATEGIES", 400693064, "DAVITA INC.", 2018, "third_quarter", "MMM", "Regulations, notices and guidances impacting people with ESRD and their ability to access care in Medicare, Medicare Advantage and the private marketplaces.\n\nRegulations, notices and guidances focused on quality measurement and social determinants of health.\n\nH.R.4143/S.2065 - Dialysis PATIENTS Demonstration Act - Support for creating a comprehensive care program for people living with End Stage Renal Disease.", "HOUSE OF REPRESENTATIVES,SENATE", 70000, null, 0, 0, "2018-10-09T15:45:30.363000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2181466"], "units": {}, "query_ms": 0.335835968144238, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}